Prophylaxis with low‐molecular‐weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phase
Open Access
- 7 January 2022
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 197 (2) , E32-E34
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic LeukemiaClinical Lymphoma Myeloma and Leukemia, 2021
- Does anticoagulation prophylaxis reduce the rate of venous thromboembolism in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy?British Journal of Haematology, 2021
- THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescentsHaematologica, 2018
- The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaJournal of Thrombosis and Thrombolysis, 2017
- Introduction to the Analysis of Survival Data in the Presence of Competing RisksCirculation, 2016
- The Chi-square test of independenceBiochemia Medica, 2013
- Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patientsBlood, 2006
- The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatmentJournal of Thrombosis and Haemostasis, 2005
- Statistics review 8: Qualitative data – tests of associationCritical Care, 2004